Status:
COMPLETED
D-Lung: An Analytics Platform for Lung Cancer Based on Deep Learning Technology
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
Department of Computer Science & Engineering, CUHK
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
Lung cancer is one of main cause of cancer death in worldwide, characterized of low 5-year survival rate of less than 20%. Pulmonary nodule is considered as the typical imaging manifestation in early ...
Eligibility Criteria
Inclusion
- Subjects with suspicious lung nodules.
- Thin-layer thoracic CT and pathology examination have been performed for suspicious lung nodules.
Exclusion
- Subjects with accompanied lesions on CT images that may interfere to lung nodules analysis
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04036903
Start Date
July 1 2018
End Date
June 30 2020
Last Update
February 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong, Prince of Wale Hospital
Hong Kong, Shatin, Hong Kong